UMIN ID: UMIN000000673
Registered date:31/12/2008
Cilostazol in Acute Ischemic Stroke Trial
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | ischemic stroke |
Date of first enrollment | 2006/11/01 |
Target sample size | 350 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Patients will be randomly selected to receive cilostazol. Patients will also be randomly selected to receive treatment with conventional therapy. |
Outcome(s)
Primary Outcome | modified Rankin scale 0-2 at 3 month |
---|---|
Secondary Outcome | Recurrence of stroke, NIHSS, JSS, Barthel Indes, modified Rankin Scale, Zung, MMSE, Neurological deterioration, Pneumonia |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1.cardiogenic embolism 2.previous ischemic stroke episode within 6 months 3.hemorrhagic stroke 4.consciousness disturbance 5.prestroke modified Rankin Scale 2<= 6.malignancy 7.pregnancy 8.allergic to cilostazol |
Related Information
Primary Sponsor | Keio University School of Medicine Department of Neurology |
---|---|
Secondary Sponsor | Tokai University Tokai University Hachioji Hospital Saitama Medical Universitygy Toyama University Iwate Medical University Juntendo University |
Source(s) of Monetary Support | None,None |
Secondary ID(s) |
Contact
public contact | |
Name | Haruhiko Hoshino |
Address | 35 Shinanomachi Shinjuku-ku Tokyo 165-8582 Japan Japan |
Telephone | 03-3353-1211 |
hhoshino-keio@umin.ac.jp | |
Affiliation | Keio University School of Medicine Department of Neurology |
scientific contact | |
Name | Norihiro Suzuki |
Address | 35 Shinanomachi Shinjuku-ku Tokyo 165-8582 Japan Japan |
Telephone | 03-3353-1211 |
Affiliation | Keio University School of Medicine Department of Neurology |